IL18 and amyotrophic lateral sclerosis: The suppression of 4-HNE, ox-LDL and IL-18 occurred early in the treatment course, and Nf-L, a well-accepted marker of neuronal structural degeneration and disease progression in ALS, was also suppressed early.